Melphalan and Radiation Therapy Followed By Lenalidomide in Treating Patients Who Are Undergoing Autologous Stem Cell Transplant for Stage I, Stage II, or Stage III Multiple Myeloma
Conditions
- Refractory Multiple Myeloma
- Smoldering Multiple Myeloma
- Stage I Multiple Myeloma
- Stage II Multiple Myeloma
- Stage III Multiple Myeloma
Interventions
- RADIATION: total marrow irradiation
- DRUG: melphalan
- PROCEDURE: peripheral blood stem cell transplantation
- BIOLOGICAL: filgrastim
- GENETIC: fluorescence in situ hybridization
- GENETIC: cytogenetic analysis
- DRUG: cyclophosphamide
- PROCEDURE: autologous-autologous tandem hematopoietic stem cell transplantation
- DRUG: lenalidomide
Sponsor
City of Hope Medical Center